Shire (SHPG) Total Stockholders Equity : $37,290 Mil (As of Sep. 2018)

View and export this data going back to 1998. Start your Free Trial

What is Shire Total Stockholders Equity?

Shire's Total Stockholders Equity for the quarter that ended in Sep. 2018 was $37,290 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shire's Book Value per Share for the quarter that ended in Sep. 2018 was $122.30. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shire's Debt-to-Equity for the quarter that ended in Sep. 2018 was 0.41.

Shire Total Stockholders Equity Historical Data

The historical data trend for Shire's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Total Stockholders Equity Chart

Shire Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Total Stockholders Equity

Get a 7-Day Free Trial

5,366.00

8,662.90

9,829.10

28,948.00

36,176.40

Shire Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Total Stockholders Equity	Get a 7-Day Free Trial															32,654.60	36,176.40	37,400.00	36,760.40	37,290.20

Shire (NAS:SHPG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shire's Book Value per Share for the quarter that ended in Sep. 2018 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(37290.2	-	0)	/	304.902
	=	122.30

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shire's Debt-to-Equity for the quarter that ended in Sep. 2018 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4248.7	+	11098)	/	37290.2
	=	0.41

Shire Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shire's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shire (SHPG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.shire.com

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Executives

James H Cavanaugh

director

265 HOTHORPE LANE, VILLANOVA PA 19085